https://doi.org/10.55788/1e5479d6
Prof. Harmony Reynolds (New York University Grossman School of Medicine, USA) presented the results of the HARP-MINOCA study (NCT02905357), designed to identify the cause of MINOCA. Accounting for up to 10% of MI, MINOCA is 3 times more prevalent in women than men and is overrepresented in women of colour, Prof. Reynolds explained. HARP-MINOCA was a prospective, multicentre, international, diagnostic observational study that included 301 female patients with a clinical diagnosis of MI. In this cohort, 170 had MINOCA, of whom 147 underwent OCT; 116 of these 147 patients also underwent CMR. Mean age was 60 years, 50% were non-white and non-Hispanic, and 45% had hypertension.
OCT identified a definite or possible culprit lesion in 67 of 147 women (46.2%; 95% CI 38.0â54.7). Multivariable analysis revealed that culprit was associated with age, abnormal angiography per site, and diabetes, but not with troponin or angiographic stenosis severity. CMR was abnormal in 86 of 116 women (74.1%; 95% CI 65.0â81.6); there was an ischaemic pattern in 62 (53.4%) and a non-ischaemic pattern in 24 (20.7%). Multivariable analysis showed abnormal CMR to be associated with higher peak troponin, creatinine, and diastolic blood pressure, but not with OCT culprit lesion or angiographic stenosis severity. Among the 116 women who underwent both OCT and CMR, a putative cause of MINOCA could be identified in 98 (84.5%; 95% CI 76.3â90.3%). Of them, 74 (64%) had MI, 17 (15%) myocarditis, 4 (3%) Takotsubo syndrome, and 3 (3%) non-ischaemic cardiomyopathies. For the remaining 18 women (16%), both the OCT and MRI scans were normal, and the cause of the MI remained elusive.
âOCT and CMR provide useful information, independently as well as in combination,â Prof. Reynolds summarised the findings. âCMR findings correlated well with OCT culprit lesions, demonstrating that non-obstructive culprit lesions are a frequent cause of MINOCA. Coronary artery spasm or thromboembolism likely caused MI/regional ischaemic injury in cases without OCT culprit. Mechanisms of MINOCA in women were often similar to mechanisms of MI-CAD: atherothrombosis with possible contribution or coronary artery spasm.â
These findings demonstrate that even if the angiogram does not show substantial artery blockage, women with symptoms and blood test findings consistent with a heart attack likely do have a heart attack and not heart inflammation, Prof. Reynolds concluded. âAdditional imaging tests can get to the root of the problem and help healthcare professionals make an accurate heart attack diagnosis for women and to help ensure these patients receive timely treatment.â
- Reynolds HR, et al. Coronary OCT and Cardiac MRI to Determine Underlying Causes of Minoca in Women. LBS.03, AHA Scientific Sessions 2020, 13â17 Nov.
- Reynolds HR, et al. Circulation 2020, Nov. 14. Doi: 10.1161/CIRCULATIONAHA.120.052008
Posted on
Previous Article
« Ticagrelor not superior to clopidogrel after elective PCI Next Article
AF monitoring following cardiovascular surgery »
« Ticagrelor not superior to clopidogrel after elective PCI Next Article
AF monitoring following cardiovascular surgery »
Table of Contents: AHA 2020
Featured articles
COVID-19 and Influenza
Fewer CV complications than expected in AHA COVID-19 Registry
Worse COVID-19 outcomes in younger obese patients
Effects of CVD in hospitalised COVID-19 patients
Unfavourable outcomes for COVID-19 patients with AF and atrial flutter
High-dose influenza vaccine in patients with CVD
Atrial Fibrillation
Vitamin D or omega 3 fatty acids do not prevent AF
Active screening for AF improves clinical outcomes
AF screening in older adults at primary care visits
CVD Risk Reduction
Clever trial design gets patients back on statins: the SAMSON trial
Polypill plus aspirin reduces cardiovascular events
Lowering LDL cholesterol in older patients is beneficial
No CV benefit from omega 3 in high-risk patients
Safety and efficacy of inclisiran for hypercholesterolemia
Remote risk management programme effective and efficient
Healthy lifestyle lowers mortality irrespective of medication burden
Heart Failure
Omecamtiv mecarbil improves outcomes in HFrEF-patients
IV iron reduces HF hospitalisation
Dapagliflozin reduces renal risk independent of CV disease status
âStrongly consider an SGLT2-inhibitor in most T2DM patientsâ
Additional HFrEF education and patient-engagement tools
Acute Coronary Syndrome
No benefit from omega-3 fatty acids after recent MI
PIONEER III trial: Drug-eluting stents comparable
Coronary and Valve Disease
Extra imaging reveals cause of MINOCA in women
Ticagrelor not superior to clopidogrel after elective PCI
Stroke
Ticagrelor/aspirin reduces stroke risk in patients with ipsilateral cervicocranial plaque
AF monitoring following cardiovascular surgery
Miscellaneous
PAD: Rivaroxaban reduces VTE risk after revascularisation
Sotatercept: potential new treatment option for PAH
Finerenone lowers CV events in diabetic CKD patients
Mavacamten effective in obstructive hypertrophic cardiomyopathy
Children exposed to tobacco smoke have worse heart function as adults
Transgender people have unaddressed heart disease risks
Intensive blood pressure lowering benefits older adults
Longer chest compression pause worsens outcomes after paediatric IHCA
Related Articles
February 17, 2021
AF screening in older adults at primary care visits
February 17, 2021
Unfavourable outcomes for COVID-19 patients with AF and atrial flutter
February 18, 2021
AF monitoring following cardiovascular surgery
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com